2-Phenoxyacetamide derivatives as SARS-CoV-2 main protease inhibitor: In silico studies

2-Phenoxyacetamide group has been identified as one of markers in the discovery and development of SARS-CoV-2 antiviral agent through its main protease (M(pro)) inhibition pathway. This study aims to study a series of 2-phenoxyacetamide derivatives using in silico method toward SARS-CoV-2 M(pro) as...

Descripción completa

Detalles Bibliográficos
Autores principales: Hariyono, Pandu, Dwiastuti, Rini, Yusuf, Muhammad, Salin, Nurul H., Hariono, Maywan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666106/
https://www.ncbi.nlm.nih.gov/pubmed/34926138
http://dx.doi.org/10.1016/j.rechem.2021.100263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666106/
https://www.ncbi.nlm.nih.gov/pubmed/34926138
http://dx.doi.org/10.1016/j.rechem.2021.100263

Ejemplares similares